Study of reducing of serum LDL-cholesterol levels by ingestion of test supplement -A randomized, double blinded, placebo controlled, parallel group comparison study- - Study of reducing of serum LDL-cholesterol levels by ingestion of test supplement

FANCL Corporation0 个研究点目标入组 90 人开始时间: 2021年3月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who routinely use pharmaceuticals, FOSHU, food with function claim, or health foods that affect serum lipid levels or lipid metabolism. 2. Subjects whose fasting serum triglyceride level are higher than 400 mg/dL at screening test. 3. Subjects who routinely use large amount of functional ingredients contained in test supplements 4. Subjects with a disease under treatment or with a history of serious disease that required medication. 5. Subjects who have or have had a serious disease such as diabetes, liver disease, kidney disease, or heart disease. 6. Subjects who are unable to perform the test according the prescribed procedure (e.g., enter web questionnaires, and web diary, fill out dietary records). 7. Subjects who are judged to be unsuitable to participate in the study based on answers of background survey. 8. Subjects who have allergy related to this study. 9. Subjects whose clinical laboratory tests, blood pressure, and physical measurements before intake of trial supplements are significantly out of the standard values. 10. Subjects who have participated in other clinical studies. 11. Subjects who intend to become pregnant or lactating. 12. Subjects judged as unsuitable for the study by the investigator for other reasons.

发起方